Danaparoid cross-reactivity with heparin-induced thrombocytopenia antibodies: Report of 12 cases

Intensive Care Medicine

Volumn 35, Issue 8, 2009, Pages 1449-1453

  Tardy Poncet, B ^a   Wolf, M ^b   Lasne, D ^c   Bauters, A ^d   Ffrench, P ^e   Elalamy, I ^f   Tardy, B ^g  

^a University Jean Monnet of Saint Etienne EA3065   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e LOUIS PRADEL HOSPITAL   (France)

^f HÔPITAL TENON   (France)

^g UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

Cardiovascular issues in the ICU; Haemostasis disorders; Thromboembolic disease

Indexed keywords

CROSS REACTING ANTIBODY; DANAPAROID; LEPIRUDIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; MALE; THROMBOCYTE COUNT; THROMBOEMBOLISM; THROMBOSIS; VENOUS THROMBOEMBOLISM;

AGED; ANTICOAGULANTS; CHONDROITIN SULFATES; CROSS REACTIONS; DERMATAN SULFATE; FEMALE; HEMOSTASIS; HEPARIN; HEPARITIN SULFATE; HIRUDINS; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES;

EID: 67650825724     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-009-1464-x     Document Type: Article

References (22)

1. K Selleng TE Warkentin A Greinacher 2007 Heparin induced thrombocytopenia in intensive care medicine Crit Care Med 35 425 438
2. R Statius Van Eps JPJ Wester FE de Ruiter MG Vervloet S Zweegman LG Thijs ARJ Girbes 2001 The incidence of heparin induced thrombocytopenia in critically ill patients with the multiple organ dysfunction syndrome Thromb Haemost 86 2719
3. TE Warkentin A Greinacher 2003 Heparin induced thrombocytopenia and cardiac surgery Ann Thorac Surg 76 2121 2131
4. LM Napolitano TE Warkentin A Almahameed SA Nasraway 2006 Heparin induced thrombocytopenia in the critical care setting: diagnosis and management Crit Care Med 34 2898 2911
5. C Garcia Heijl T Leclerc L Bargues T Samson V Foissaud 2008 Incidence and features of heparin induced thrombocytopenia in burn patients: a retrospective study Thromb Haemost 99 974 976
6. IA Hourigan DL Walters SA Keck 2002 Heparin induced thrombocytopenia: a common complication in cardiac transplant recipients J Heart Lung Transplant 21 1283 1289
7. M Schmugge L Risch AR Huber 2002 Heparin induced thrombocytopenia associated thrombosis in pediatric intensive care patients Pediatrics 109 E10
8. TH Warkentin A Greinacher A Koster AM Lincoff 2008 Treatment and prevention of heparin induced thrombocytopenia: American College of Chest Physicians evidence-based clinical practice Guidelines Chest 133 340S 380S
9. B Farner P Eichler H Kroll A Greinacher 2001 A comparison of danaparoid and lepirudin in heparin induced thrombocytopenia Thromb Haemost 85 950 957
10. BH Chong HN Magnani 1992 Orgaran in heparin induced thrombocytopenia Haemostasis 22 85 91
11. TE Warkentin 1996 Danaparoid (Orgaran) for the treatment of heparin induced thrombocytopenia (HIT) and thrombosis: effects on in vivo thrombin and cross-linked fibrin generation, and evaluation of the clinical significance of in vitro cross-reactivity of danaparoid for HIT-IgG Blood 88 626a Abstract 2493
12. PM Newman RL Swanson BH Chong 1998 Heparin induced thrombocytopenia: IgG binding to PF4-heparin complexes in the fluid phase and cross-reactivity with low molecular weight heparin and heparinoid Thromb Haemost 80 292 297
13. HN Magnani A Gallus 2006 Heparin induced thrombocytopenia: a report of 1 478 clinical outcomes of patients treated with danaparoid (Orgaran) from 1982 to mid 2004 Thromb Haemost 95 967 981
14. B Tardy T Lecompte F Boehlen B Tardy-Poncet I Elalamy B Morange for the GEHT-HIT Study Group 2006 Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin induced thrombocytopenia treated with lepirudin Blood 108 1492 1496
15. D Sheridan C Carter JG Kelton 1986 A diagnostic test for heparin induced thrombocytopenia Blood 67 27 30
16. BH Chong J Burgess F Ismail 1992 The clinical usefulness of the platelet aggregation test for the diagnosis of heparin induced thrombocytopenia Thromb Haemost 68 95 96
17. BK Keng BH Chong 2001 Heparin induced thrombocytopenia and thrombosis syndrome: in vivo cross-reactivity with danaparoid and successful treatment with r-hirudin Br J Haematol 114 394 396
18. MW Baumgartel P Eichler W Glockner O Ranze A Greinacher 2000 Heparin induced thrombocytopenia: in vitro and in vivo cross-reactivity to danaparoid sodium and successful treatment with recombinant hirudin Eur J Haematol 65 148 149
19. B Tardy B Tardy-Poncet A Viallon M Piot E Mazet 1998 Fatal danaparoid sodium induced thrombocytopenia and arterial thrombosis Thromb Haemost 80 530
20. I Elalamy C Lecrubier F Potevin MM Samama 1999 Danaparoid therapy in HIT syndrome and cross-reactivity: study of 67 patients Thromb Haemost 59 175
21. B Tardy-Poncet B Tardy J Reynaud P Mahul P Mismetti E Mazet D Guyotat 1999 Efficacy and safety of danaparoid sodium (ORG 10172) in critically ill patients with heparin associated thrombocytopenia Chest 115 1616 1620
22. Conférence d'experts 2002 Heparin induced thrombocytopenia Ann Fr Anesth Reanim 22 150 159